trending Market Intelligence /marketintelligence/en/news-insights/trending/ErtzXlcNm9F2gsV-DhGP7g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Fitch affirms Boston Scientific's long-term issuer default rating

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Fitch affirms Boston Scientific's long-term issuer default rating

Fitch Ratings affirmed Boston Scientific Corp.'s BBB long-term issuer default rating with a stable outlook.

The rating action applies to about $10.9 billion of debt as of Sept. 30.

Marlborough, Mass.-based Boston Scientific's gross debt to EBITDA ratio is currently high due to the largely debt-financed $4.2 billion acquisition of London-based pharmaceutical company BTG Ltd.

Fitch expects that the company will prioritize leverage reduction over share repurchases and reduce it to about 2.5x by the end of 2020. Leverage is a measure of debt a firm uses to finance its operations.

With reduced contingent liability risk, particularly regarding litigation and taxes, Fitch believes the company will have more flexibility to pursue targeted acquisitions without incurring noticeable debt. In addition, Fitch expects Boston Scientific to continue launching new products in the market with focus on shifting to the high-growth markets.

Boston Scientific is a medical device company that provides physicians with devices used in different areas of healthcare.